Obstructive Sleep ApneaSymptoms, Doctors, Treatments, Advances & More
Learn About Obstructive Sleep Apnea
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Penn Sleep Center Radnor
Richard Schwab is a Sleep Medicine provider practicing medicine in Radnor, Pennsylvania. Dr. Schwab is rated as an Elite provider by MediFind in the treatment of Obstructive Sleep Apnea. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, Excessive Daytime Sleepiness, Drowsiness, Narcolepsy, and Endoscopy. Dr. Schwab is board certified in Sleep Medicine (ABIM), 2009 and Internal Medicine, 1986. Dr. Schwab is currently accepting new patients.
Susan Redline is a Cardiologist and a Sleep Medicine provider practicing medicine in Cleveland, Ohio. Dr. Redline is rated as an Elite provider by MediFind in the treatment of Obstructive Sleep Apnea. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Obstructive Sleep Apnea, Excessive Daytime Sleepiness, Cerebral Hypoxia, Central Sleep Apnea, and Adenoidectomy. Dr. Redline is board certified in Internal Medicine and Pulmonary Disease.
Pulmonary Division - Sleep Wake Center
Krishna Sundar is a Sleep Medicine provider practicing medicine in Salt Lake City, Utah. Dr. Sundar is rated as an Elite provider by MediFind in the treatment of Obstructive Sleep Apnea. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, Chronic Cough, Central Sleep Apnea, and Cerebral Hypoxia. Dr. Sundar is board certified in American Board Of Psychiatry And Neurology. Dr. Sundar is currently accepting new patients.
Summary: This Phase 3 clinical trial is designed to evaluate the efficacy and safety of maridebart cafraglutide compared to placebo over a 52-week period in adults with obstructive sleep apnea (OSA) who are not on PAP therapy and are living with overweight or obesity.
Summary: This Phase 3 clinical trial is designed to evaluate the efficacy and safety of maridebart cafraglutide compared to placebo over a 52-week period in adults with obstructive sleep apnea (OSA) who are receiving positive airway pressure (PAP) therapy and are living with overweight or obesity.